✦ LIBER ✦

Multicenter phase II trial of three-weekly docetaxel and weekly trastuzumab in HER-2-overexpressing metastatic breast cancer patients: Japan East cancer center breast cancer consortium (JECBC 01 trial)

✍ Scribed by T Tabei; M Kimura; M Sano; T Asaga; J Ando; H Fujii; N Yamamoto; M Kurosumi; K Inoue; N Sato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly docetaxel and trastuzumab for her

✍ S Takao; N Kohno; M Miyashita; I Kokufu; K Wakita 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Combination docetaxel and trastuzumab tr

✍ Nobuaki Sato; Muneaki Sano; Toshio Tabei; Taro Asaga; Jiro Ando; Hirofumi Fujii; 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 553 KB

Phase II study of weekly docetaxel (Taxo

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

A phase II study of trastuzumab and cape

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

A phase II multicenter trial of weekly h

✍ M. Jahanzeb; J. Mortimer; F. Yunus; D. Irwin; J. Speyer; A. Koletsky; P. Klein; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

A phase II trial of trastuzumab plus wee

✍ Stacy Moulder; Hailun Li; Molin Wang; William J. Gradishar; Edith A. Perez; Jose 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 250 KB